Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Xylem Inc. (NYSE:XYL) Stock Has Consensus Target Price of $140.85

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Xylem has a “Moderate Buy” consensus rating from 16 analysts, evenly split between buy and hold recommendations, with an average 12-month price target of $140.85.
  • Recent analyst views were mixed: UBS and Mizuho cut their price targets to $112 and $110, respectively, while Barclays maintained an overweight rating and Jefferies raised its target to $150 with a buy rating.
  • Xylem’s latest quarterly results beat expectations, with EPS of $1.46 versus a $1.34 consensus estimate and revenue of $2.34 billion. The company also pays a quarterly dividend of $0.43, representing a 1.6% yield.
  • Get every upgrade, downgrade, and earnings report on Xylem as it happens. Lock in MarketBeat All Access for $149 a year through October 30.

Shares of Xylem Inc. (NYSE:XYL - Get Free Report) have earned an average rating of "Moderate Buy" from the sixteen research firms that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $140.85.

Several brokerages recently weighed in on XYL. UBS Group cut their target price on shares of Xylem from $138.00 to $112.00 and set a "neutral" rating for the company in a research note on Monday, October 5th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Xylem in a research note on Wednesday, August 5th. Mizuho lowered their price target on shares of Xylem from $130.00 to $110.00 and set a "neutral" rating for the company in a report on Thursday, October 15th. Barclays lowered their price target on shares of Xylem from $159.00 to $139.00 and set an "overweight" rating for the company in a report on Tuesday, October 13th. Finally, Jefferies Financial Group boosted their price objective on shares of Xylem from $145.00 to $150.00 and gave the company a "buy" rating in a research report on Monday, August 24th.

Read Our Latest Stock Analysis on Xylem

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Oregon Public Employees Retirement Fund increased its stake in Xylem by 0.4% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 27,923 shares of the industrial products company's stock worth $3,337,000 after acquiring an additional 100 shares during the last quarter. Thrive Wealth Management LLC raised its holdings in shares of Xylem by 2.1% during the 2nd quarter. Thrive Wealth Management LLC now owns 5,032 shares of the industrial products company's stock worth $595,000 after acquiring an additional 104 shares in the last quarter. World Investment Advisors raised its holdings in shares of Xylem by 3.7% during the 1st quarter. World Investment Advisors now owns 3,319 shares of the industrial products company's stock worth $397,000 after acquiring an additional 119 shares in the last quarter. Aventus Investment Advisors Inc. boosted its position in shares of Xylem by 66.7% during the 2nd quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company's stock valued at $35,000 after acquiring an additional 120 shares during the last quarter. Finally, Rockland Trust Co. boosted its position in shares of Xylem by 3.6% during the 3rd quarter. Rockland Trust Co. now owns 3,582 shares of the industrial products company's stock valued at $363,000 after acquiring an additional 124 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Stock Performance

Xylem stock opened at $108.86 on Monday. Xylem has a fifty-two week low of $98.58 and a fifty-two week high of $154.27. The company has a market capitalization of $25.42 billion, a price-to-earnings ratio of 25.92, a PEG ratio of 1.75 and a beta of 1.00. The stock has a fifty day moving average of $106.94 and a two-hundred day moving average of $113.35. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. The business's revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, analysts anticipate that Xylem will post 5.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were issued a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem's payout ratio is 40.95%.

Xylem Company Profile

(Get Free Report)

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

Further Reading

Analyst Recommendations for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines